Global healthcare and private health insurance markets are entering a period of significant strain and transformation.
Health needs are evolving, populations are ageing, chronic disease is rising faster than health systems can respond, and care is becoming more complex.
This is placing public health systems under increasing strain in many countries, with customers turning to private providers for faster access to care and ongoing support.
Health insurance in the digital age
Compared to traditional health insurance holders, customers today are more digital, selective and value focused. As a result, they are becoming more open to new products and propositions that address their increasingly complex care needs. This is impacting how customers purchase health insurance, how they engage with it and how they claim.
Digital health services such as virtual GP access and guided mental healthcare help insurers build ongoing relationships with customers across a range of health needs. These tools also support preventive and early intervention strategies that can improve customer health while reducing claim severity and frequency for insurers.
The industry is also shifting away from generic digital health services with low usage and limited relevance toward more personalised support. Finding ways to use AI to connect customers with tailored digital and health services helps them see more value in their cover, making them more likely to stay with their insurer over the long term.
Analytics for profitable growth
Insurers have made strong progress in expanding participation, but the next challenge is retaining the right customers – those who represent good risk – and predictive analytics will be key.
Digitalisation is generating more data, while personalisation relies on advanced analytics behind the scenes to determine contextually appropriate actions for different customer groups. Machine learning is providing more granular insights, helping insurers identify high-value segments that traditional one-way, two-way or linear analyses may miss.
Insurers must also assess which customer groups support both growth and long-term profitability objectives. The business mix needs to align with pricing assumptions, while customer mix and claims performance should be monitored closely to ensure they remain in line with expectations. Robust dashboards and analytics strategies will be essential to detecting warning signs early and identifying profitable opportunities to expand market share.
Data-driven innovation improving access to new treatments
Promising new treatments for cancer, cardiovascular disease, and neurodegenerative disorders are emerging, but proving value at scale takes time.
In product development, supplementary riders are creating access to these new technologies and treatments while protecting the core book from rising medical inflation. Instead of offering costly new treatments across the entire portfolio from the outset, insurers can ring-fence them as optional add-ons for customers. This allows insurers to gather evidence on outcomes, value and cost-effectiveness, while offering access to customers who want it without undermining the sustainability of the core health insurance book.
The next opportunity is to combine personalised diagnostics and treatments with propositions enabled by AI and digital transformation. This could help insurers develop products that deliver cutting-edge treatments to the customers who need them most.
Meanwhile, pricing and claims monitoring can be improved through advanced modelling techniques, such as gradient boosting machines (GBMs) and dynamic portfolio management. Insurers should also enable pricing teams to deploy machine learning models more independently, reducing reliance on IT as new rating factors emerge.
The convergence imperative for health insurers
Partnerships among insurers, digital health providers, hospitals, care providers and technology platforms will play an increasingly important role in health insurance. For future insurers, success will depend on delivering more integrated care by combining the best of healthcare and technology. This will require better use of data, underpinned by customer trust, strong data security and transparency about how information is used.
Insurers must also grow sustainably by attracting the right customers, improving health outcomes and reducing claims costs over time. Closer collaboration with providers will be essential, despite longstanding differences in priorities and performance measures.
Insurers that stay passive will face rising loss ratios, worsening affordability and declining relevance. Those that act will find themselves in a far stronger position to help shape the future of global healthcare.